[
  {
    "objectID": "about.html",
    "href": "about.html",
    "title": "Michael Scherzer‚Äôs Research Publications",
    "section": "",
    "text": "Full list here @ Google Scholar"
  },
  {
    "objectID": "index.html",
    "href": "index.html",
    "title": "Michael Scherzer, PhD",
    "section": "",
    "text": "Email"
  },
  {
    "objectID": "projects.html",
    "href": "projects.html",
    "title": "projects",
    "section": "",
    "text": "This is a Quarto website.\nTo learn more about Quarto websites visit https://quarto.org/docs/websites.\n\n1 + 1\n\n[1] 2"
  },
  {
    "objectID": "protect/projects.html",
    "href": "protect/projects.html",
    "title": "projects",
    "section": "",
    "text": "This is a Quarto website.\nTo learn more about Quarto websites visit https://quarto.org/docs/websites.\n\n1 + 1\n\n[1] 2"
  },
  {
    "objectID": "protect/4d597a22f3d1d9820f12e0ccd8827182206db609/projects.html",
    "href": "protect/4d597a22f3d1d9820f12e0ccd8827182206db609/projects.html",
    "title": "projects",
    "section": "",
    "text": "This is a Quarto website.\nTo learn more about Quarto websites visit https://quarto.org/docs/websites.\n\n1 + 1\n\n[1] 2"
  },
  {
    "objectID": "protect/#4d597a22f3d1d9820f12e0ccd8827182206db609/projects.html",
    "href": "protect/#4d597a22f3d1d9820f12e0ccd8827182206db609/projects.html",
    "title": "projects",
    "section": "",
    "text": "This is a Quarto website.\nTo learn more about Quarto websites visit https://quarto.org/docs/websites.\n\n1 + 1\n\n[1] 2"
  },
  {
    "objectID": "protect/4d597a22f3d1d9820f12e0ccd8827182206db609/index.html",
    "href": "protect/4d597a22f3d1d9820f12e0ccd8827182206db609/index.html",
    "title": "Michael Scherzer",
    "section": "",
    "text": "december 21st , 2022 Microarray analysis of Damsky et al Cancer cell paper\n\n\n\n\nBRAF mut+CDKN2A null growth arrested melanocytes (P50) VS BRAF mut+CDKN2A null melanomas"
  },
  {
    "objectID": "index.html#experience",
    "href": "index.html#experience",
    "title": "Michael Scherzer, PhD",
    "section": "Experience",
    "text": "Experience\n\nPost-Doctoral Scientist with Dr.¬†Robert Judson-Torres\nüß™ May 2022 - present: Modulating melanocytic cell-states as a potential strategy for melanoma interception\n\n\nGrduate Student with Dr.¬†Martin McMahon\nüêÅ 2016 - 2022: Characterized mouse models of Lung Adenocarcinoma"
  },
  {
    "objectID": "hobby.html",
    "href": "hobby.html",
    "title": "Curriculum vitae",
    "section": "",
    "text": "Download current CV"
  },
  {
    "objectID": "protect/6986f36e11e383a09b18c52140c1f157c551759f/index.html",
    "href": "protect/6986f36e11e383a09b18c52140c1f157c551759f/index.html",
    "title": "Michael Scherzer",
    "section": "",
    "text": "december 21st , 2022 Microarray analysis of Damsky et al Cancer cell paper\n\n\n\n\nBRAF mut+CDKN2A null growth arrested melanocytes (P50) VS BRAF mut+CDKN2A null melanomas"
  },
  {
    "objectID": "index.html#most-recent-publication",
    "href": "index.html#most-recent-publication",
    "title": "Michael Scherzer, PhD",
    "section": "Most Recent Publication",
    "text": "Most Recent Publication\nCommentary:Perilesional Epigenomes Distinguish Melanocytic Nevus Subtypes"
  },
  {
    "objectID": "cv/index.html",
    "href": "cv/index.html",
    "title": "Curriculum vitae",
    "section": "",
    "text": "Download current CV"
  },
  {
    "objectID": "publications/index.html",
    "href": "publications/index.html",
    "title": "Publications",
    "section": "",
    "text": "Perilesional Epigenomes Distinguish Melanocytic Nevus Subtypes \n            \n            \n                Fall 2023 | \n                Journal of Investigative dermatology\n            \n             \n                Michael Scherzer, Dekker Deacon, Robert Judson-Torres\n            \n            Commentary on recent JID publication that describes differential methylation in normal skin adjacent to different nevus subtypes\n            \n                 Volume 143,Issue 9, p1631-1633\n            \n        \n    \n\n\nNo matching items"
  },
  {
    "objectID": "publications/index.html#section-1",
    "href": "publications/index.html#section-1",
    "title": "Publications",
    "section": "2022‚Äì23",
    "text": "2022‚Äì23\n\n\n    \n        \n            \n        \n        \n            \n                Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis \n            \n            \n                Fall 2022 | \n                Cancer Research\n            \n             \n                Vaishnavi A, Juan J, Jacob M, Stehn C, Gardner EE, Scherzer MT, Schuman S, Van Veen JE, Newberg JY, Liu A, Mann K, Adams DJ, Grossmann A, Mann MB, McMahon M.\n            \n            Sleeping Beauty Mutagenesis screen to identify tumor supressors in BRAF-mutant Lung cancer\n            \n                 Volume 82,Issue 22, p4261‚Äì4273\n            \n        \n    \n\n\nNo matching items"
  },
  {
    "objectID": "publications/index.html#section-2",
    "href": "publications/index.html#section-2",
    "title": "Publications",
    "section": "2020‚Äì21",
    "text": "2020‚Äì21\n\n\n    \n        \n            \n        \n        \n            \n                Inhibition of MEK1/2 Forestalls the Onset of Acquired Resistance to Entrectinib in Multiple Models of NTRK1-Driven Cancer \n            \n            \n                Fall 2020 | \n                Cell Reports\n            \n             \n                Vaishnavi A, Scherzer MT, Kinsey CG, Parkman GL, Truong A, Ghazi P, Schuman S, Battistone B, Garrido-Laguna I, McMahon M.\n            \n            Created new models of kinase-fusion driven lung cancer and studied their response to MAPKI\n            \n                 Volume 32,Issue 5\n            \n        \n    \n    \n        \n            \n        \n        \n            \n                Chloroquine Sensitizes GNAQ/11-mutated Melanoma to MEK1/2 Inhibition \n            \n            \n                Winter 2020 | \n                Clinical Cancer Research\n            \n             \n                Vaishnavi A, Juan J, Jacob M, Stehn C, Gardner EE, Scherzer MT, Schuman S, Van Veen JE, Newberg JY, Liu A, Mann K, Adams DJ, Grossmann A, Mann MB, McMahon M.\n            \n            Studied the resistance mechanisms of uveal melanoma cells to the combination of MAPK- and autophaghy- inhibition\n            \n                 Volume 26,Issue 23, p6374‚Äì6386\n            \n        \n    \n\n\nNo matching items"
  },
  {
    "objectID": "publications/index.html#section-3",
    "href": "publications/index.html#section-3",
    "title": "Publications",
    "section": "2019‚Äì20",
    "text": "2019‚Äì20\n\n\n    \n        \n            \n        \n        \n            \n                Mutationally- activated PI3K promotes de-differentiation of lung tumors initiated by the BRAF(V600E) oncoprotein kinase \n            \n            \n                Fall 2019 | \n                eLife\n            \n             \n                J Edward van Veen , Michael Scherzer, Julia Boshuizen, Mollee Chu, Annie Liu, Allison Landman, Shon Green, Christy Trejo, Martin McMahon\n            \n            Created a new mouse model to fluorescently tag BRAF and used it to study changes in the transcriptome\n            \n                 https://doi.org/10.7554/eLife.43668\n            \n        \n    \n\n\nNo matching items"
  },
  {
    "objectID": "publications/index.html#section-4",
    "href": "publications/index.html#section-4",
    "title": "Publications",
    "section": "2013‚Äì16",
    "text": "2013‚Äì16\n\n\n    \n        \n            \n        \n        \n            \n                Suramin Protects against cisplatin-induced acute kidney injury \n            \n            \n                Winter 2016 | \n                American Journal of Physiology Renal Pathology\n            \n             \n                Dupre, T., Doll, M., Shah, P., Sharp, C., Kiefer, A., Scherzer MT, Siskind, L.\n            \n            Tested the efficacy of suramin to protect against cisplastin toxicities\n            \n                 Volume 310,Issue 3, Pages F248-F258\n            \n        \n    \n    \n        \n            \n        \n        \n            \n                Fibroblast-Derived Extracellular Matrices As An Alternative Cell Culture System That Increases Metastatic Cellular Properties \n            \n            \n                Fall 2015 | \n                Plos One\n            \n             \n                Scherzer, MT, Waigel, S, Donninger H, Arumugam V, Zacharias, W, Clark, G, Siskind, L, Soucy, P, Beverly, L.\n            \n            Created Fibroblast-derived Matrices to compare the cell biology of lung cancer cells in 2D vs 3D\n            \n                 https://doi.org/10.1371/journal.pone.0138065\n            \n        \n    \n    \n        \n            \n        \n        \n            \n                The PIM family of oncoproteins are small kinases with huge implications in myeloid leukemogenesis and as therapeutic targets \n            \n            \n                Fall 2014 | \n                Oncotarget\n            \n             \n                Saurabh K*, Scherzer, MT*, SHah, P, Mims, A, Lockwood, W, Kraft A, Beverly LJ.\n            \n            Used in vitro and in vivo models of leukemia to test cooperation of all three PIM kinases to cooperate with MYC\n            \n                 https://doi.org/10.18632/oncotarget.2330\n            \n        \n    \n    \n        \n            \n        \n        \n            \n                Dissecting the In Vivo Leukemogenic Potency of BCLxl \n            \n            \n                Fall 2014 | \n                Journal of Leukemia\n            \n             \n                Saurabh K*, Scherzer, MT*, Song A, Yip KW, Reed JC, et al.\n            \n            Here we swapped BH domains of different BCL proteins to determine oncogenic potency\n            \n                 DOI 10.4172/2329-6917.1000158\n            \n        \n    \n\n\nNo matching items"
  },
  {
    "objectID": "projects/index.html",
    "href": "projects/index.html",
    "title": "Projects",
    "section": "",
    "text": "ill put stuff hereill put stuff hereill put stuff hereill put stuff hereill put stuff hereill put stuff hereill put stuff hereill put stuff hereill put stuff here ill put stuff hereill put stuff hereill put stuff hereill put stuff hereill put stuff hereill put stuff hereill put stuff hereill put stuff hereill put stuff here ill put stuff hereill put stuff hereill put stuff hereill put stuff hereill put stuff hereill put stuff hereill put stuff hereill put stuff hereill put stuff here"
  },
  {
    "objectID": "projects/index.html#chemopreventative-methods-for-melanoma-interception",
    "href": "projects/index.html#chemopreventative-methods-for-melanoma-interception",
    "title": "Projects",
    "section": "Chemopreventative methods for melanoma interception",
    "text": "Chemopreventative methods for melanoma interception\n\nill put stuff hereill put stuff hereill put stuff hereill put stuff hereill put stuff hereill put stuff hereill put stuff hereill put stuff hereill put stuff here ill put stuff hereill put stuff hereill put stuff hereill put stuff hereill put stuff hereill put stuff hereill put stuff hereill put stuff hereill put stuff here ill put stuff hereill put stuff hereill put stuff hereill put stuff hereill put stuff hereill put stuff hereill put stuff hereill put stuff hereill put stuff here"
  }
]